Aura Biosciences, Inc. (AURA): Price and Financial Metrics
GET POWR RATINGS... FREE!
AURA Stock Price Chart Interactive Chart >
AURA Price/Volume Stats
| Current price | $10.41 | 52-week high | $24.83 |
| Prev. close | $10.58 | 52-week low | $9.43 |
| Day low | $10.09 | Volume | 111,870 |
| Day high | $10.61 | Avg. volume | 101,563 |
| 50-day MA | $11.67 | Dividend yield | N/A |
| 200-day MA | $14.16 | Market Cap | 305.38M |
Aura Biosciences, Inc. (AURA) Company Bio
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Latest AURA News From Around the Web
Below are the latest news stories about AURA BIOSCIENCES INC that investors may wish to consider to help them evaluate AURA as an investment opportunity.
Institutional investors may adopt severe steps after Aura Biosciences, Inc.'s (NASDAQ:AURA) latest 11% drop adds to a year lossesA look at the shareholders of Aura Biosciences, Inc. ( NASDAQ:AURA ) can tell us which group is most powerful. And the... |
12 Stocks Insiders are Buying NowIn this article, we will look at the 12 stocks insiders are buying now. If you want to explore similar stocks, you can also take a look at 5 Stocks Insiders are Buying Now. Investing in stocks that insiders are buying can sometimes lead to unexpected gains. Insiders, such as company executives, board members, and major […] |
Aura Biosciences Inc. (NASDAQ:AURA) stock: Is this a flash in the pan today?Aura Biosciences Inc. (AURA)’s stock has witnessed a price declined of -17.86% from the previous close with its current price standing at $11.73. Its current price is -52.76% under its 52-week high of $24.83 and 3.17% more than its 52-week low of $11.37. Based on the past 30-day period, the stock price is -18.92% below […] |
Aura Biosciences Announces Pricing of Public Offering of Common StockAura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) the |
Aura Biosciences Announces Proposed Public Offering of Common StockAura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) the |
AURA Price Returns
| 1-mo | -0.86% |
| 3-mo | -15.57% |
| 6-mo | -27.05% |
| 1-year | -42.96% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -0.86% |
| 2022 | -38.16% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...